Información del artículo
Resumen
Objetivo
Determinar la asociación entre los polimorfismos IL-1B-511, IL-1RN, TNF-α-308, IL-10-819 e IL-101082 y la infección por Helicobacter pylori CagA positivo en un grupo de pacientes con cáncer gástrico y úlcera duodenal en diferentes poblaciones en Colombia.
MétodosEstudio de casos y controles con 341 pacientes: con gastritis no atrófica, 194; con cáncer gástrico, 58; úlcera duodenal con lesiones preneoplásicas, 54; y con úlcera duodenal, 35. La genotipificación de los polimorfismos se hizo por discriminación alélica usando PCR en tiempo real, y la del IL-1RN, por PCR convencional y electroforesis en agarosa. La infección por Helicobacter pylori CagA se determinó mediante ELISA. Se utilizó la regresión logística en el análisis estadístico.
ResultadosSer portador del genotipo IL-1B-511TT (OR=4,69; IC 95% 1,22-18,09) y tener una infección por Helicobacter pylori CagA positivo (OR=4,43; IC 95% 1,72–11,4) se asociaron a cáncer gástrico. Tener una infección por Helicobacter pylori CagA positivo (OR=4,39; IC95% 1,82–10,59) se asoció a la presencia de úlcera duodenal con lesiones preneoplásicas, y ser portador del genotipo IL-1B-511CT se asoció a úlcera duodenal (OR=0,30; IC 95% 0,10–0,91).
ConclusiónLos resultados sugieren que la respuesta pro-inflamatoria y la genética virulenta de la bacteria son factores relacionados con los diferentes desenlaces ocasionados por la infección por Helicobacter pylori en la población estudiada; así, el polimorfismo IL-1B-511 es un factor relacionado con cáncer gástrico y úlcera duodenal, y la infección por Helicobacter pylori CagA positivo es un factor asociado a cáncer gástrico y úlcera duodenal con lesiones preneoplásicas.
Palabras clave:
Interleucinas 1B
10
factor de necrosis tumoral alpha
Helicobacter pylori
proteína cagA
neoplasias de estomago
ulcera duodenal
Abstract
Objective
To determine the association between the IL-1B-511, IL-1RN, TNF-α-308, IL-10-819 and IL-101082 polymorphisms and positive Heliocobacter pylori CagA infection in a group of patients with gastric cancer and duodenal ulcer in different populations in Colombia.
MethodsA case-control study was performed on 341 patients: those with non-atrophic gastritis, 194; with gastric cancer, 58; duodenal ulcer with preneoplastic lesion, 54; and with duodenal ulcer, 35. The genotyping of polymorphisms was done with allelic discrimination using PCR in real time, and that for IL-1RN with conventional PCR and agarose electrophoresis. Helicobacter pylori CagA infection was ascertained with ELISA. Logistic regression was used in statistical analysis.
ResultsBeing a carrier of genotype IL-1B-511TT (OR=4.69; CI 95% 1.22–18.09) and being positive for Helicobacter pylori CagA infection (OR=4.43; CI 95% 1.72–11.4) are associated with gastric cancer. Positive Helicobacter pylori CagA infection (OR=4.39; CI 95% 1.82–10.59) is associated with the presence of duodenal ulcer with preneoplastic lesions, being a carrier of genotype IL-1B-511CT is associated with duodenal ulcer (OR=0.30; CI 95% 0.10–0.91).
ConclusionThe results suggest that pro-inflammatory response and virulent bacterial genetics are factors related to the different outcomes brought about by Helicobacter pylori infection in the population studied; that is, the IL-1B-511 polymorphism is a factor related to gastric cancer and duodenal ulcer, and positive Helicobacter pylori CagA infection is a factor associated with gastric cancer and duodenal ulcer with preneoplastic lesions.
Key words:
Interleukins 1B
10
tumor necrosis factor-alpha
Helicobacter pylori
cagA protein
stomach neoplasm
duodenal ulcer
El Texto completo está disponible en PDF
Referencias
[1.]
D.M. Parkin, F. Bray, J. Ferlay, et al.
Global cancer statistics, 2002.
CA Cancer J Clin, 55 (2005), pp. 74-108
[2.]
Instituto Nacional de Cancerología (INC) Colombia. Cáncer en cifras. Mortalidad. Mortalidad nacional por tipo de cáncer. Mortalidad por cáncer según primeras causas y sexo, 2000-2006 [internet]. 2006 [citado: 5 de noviembre del 2010]. Disponible en: http://cancer.gov.co/
[3.]
M. Piñeros, G. Hernández, F. Bray.
Increasing mortality rates of common malignancies in Colombia: an emerging problem.
Cancer, 101 (2004), pp. 2285-2292
[4.]
C.F. Zambon, F. Navaglia, D. Basso, et al.
Helicobacter pylori babA2, cagA, and s1 vacA genes work synergistically in causing intestinal metaplasia.
J Clin Pathol, 56 (2003), pp. 287-291
[5.]
C.F. Zambon, D. Basso, F. Navaglia, et al.
Helicobacter pylori virulence genes and host IL-1RN and IL-1beta genes interplay in favouring the development of peptic ulcer and intestinal metaplasia.
Cytokine, 18 (2002), pp. 242-251
[6.]
S. Holck, A. Norgaard, M. Bennedsen, et al.
Gastric mucosal cytokine responses in Helicobacter pylori-infected patients with gastritis and peptic ulcers. Association with inflammatory parameters and bacteria load.
FEMS Immunol Med Microbiol, 36 (2003), pp. 175-180
[7.]
P. Sutton, T. Kolesnikow, S. Danon, et al.
Dominant nonresponsiveness to Helicobacter pylori infection is associated with production of interleukin 10 but not gamma interferon.
Infect Immun, 68 (2000), pp. 4802-4804
[8.]
T. Furuta, E.M. El-Omar, F. Xiao, et al.
Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan.
Gastroenterology, 123 (2002), pp. 92-105
[9.]
I.R. Hwang, T. Kodama, S. Kikuchi, et al.
Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection.
Gastroenterology, 123 (2002), pp. 1793-1803
[10.]
E.M. El-Omar, I.D. Penman, J.E. Ardill, et al.
Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease.
Gastroenterology, 109 (1995), pp. 681-691
[11.]
N. Uemura, S. Okamoto, S. Yamamoto, et al.
Helicobacter pylori infection and the development of gastric cancer.
N Engl J Med, 345 (2001), pp. 784-789
[12.]
M.C. Camargo, R. Mera, P. Correa, et al.
Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis.
Cancer Epidemiol Biomarkers Prev, 15 (2006), pp. 1674-1687
[13.]
M. Loh, K.X. Koh, B.H. Yeo, et al.
Meta-analysis of genetic polymorphisms and gastric cancer risk: variability in associations according to race.
Eur J Cancer, 45 (2009), pp. 2562-2568
[14.]
H. Xue, B. Lin, P. Ni, et al.
Interleukin-1B and interleukin-1 RN polymorphisms and gastric carcinoma risk: a metaanalysis.
J Gastroenterol Hepatol, 25 (2010), pp. 1604-1617
[15.]
M.A. García-González, A. Lanas, P.H. Savelkoul, et al.
Association of interleukin 1 gene family polymorphisms with duodenal ulcer disease.
Clin Exp Immunol, 134 (2003), pp. 525-531
[16.]
N. Kim, S.I. Cho, J.Y. Yim, et al.
The effects of genetic polymorphisms of IL-1 and TNF-A on Helicobacter pylori- induced gastroduodenal diseases in Korea.
Helicobacter, 11 (2006), pp. 105-112
[17.]
F. Gorouhi, F. Islami, H. Bahrami, et al.
Tumour-necrosis factor- A polymorphisms and gastric cancer risk: a meta-analysis.
Br J Cancer, 98 (2008), pp. 1443-1451
[18.]
J. Zhang, C. Dou, Y. Song, et al.
Polymorphisms of tumor necrosis factor-alpha are associated with increased susceptibility to gastric cancer: a meta-analysis.
J Hum Genet, 53 (2008), pp. 479-489
[19.]
M.A. García-González, P.H. Savelkoul, R. Benito, et al.
No allelic variant associations of the IL-1 and TNF gene polymorphisms in the susceptibility to duodenal ulcer disease.
Int J Immunogenet, 32 (2005), pp. 299-306
[20.]
Y. Zhou, N. Li, W. Zhuang, et al.
Interleukin-10-1082 promoter polymorphism associated with gastric cancer among Asians.
Eur J Cancer, 44 (2008), pp. 2648-2654
[21.]
K.F. Chen, B. Li, Y.G. Wei, et al.
Interleukin-10-819 promoter polymorphism associated with gastric cancer among Asians.
J Int Med Res, 38 (2010), pp. 1-8
[22.]
C.F. Zambon, D. Basso, F. Navaglia, C. Belluco, A. Falda, P. Fogar, et al.
Pro-and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome.
Cytokine, 29 (2005), pp. 141-152
[23.]
J.M. Kang, N. Kim, D.H. Lee, et al.
The effects of genetic polymorphisms of IL-6, IL-8, and IL-10 on Helicobacter pylori-induced gastroduodenal diseases in Korea.
J Clin Gastroenterol, 43 (2009), pp. 420-428
[24.]
M.T. Arango, C. Jaramillo, M.C. Montealegre, et al.
Genotipificación de los polimorfismos -511 -31 y +3954 del gen de la interleucina-1β humana en una población colombiana con cuadro de dispepsia.
Biomedica, 30 (2010), pp. 199-206
[25.]
M.M. Torres, C.P. Acosta, D.M. Sicard, et al.
Genetic susceptibility and risk of gastric cancer in a human population of Cauca, Colombia.
Biomedica, 24 (2004), pp. 153-162
[26.]
M.F. Dixon, R.M. Genta, J.H. Yardley, et al.
Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994.
Am J Surg Pathol, 20 (1996), pp. 1161-1181
[27.]
P. Lauren.
The Two Histological Main Types of Gastric Carcinoma: Diffuse and So-Called Intestinal-Type Carcinoma. an Attempt at a Histo-Clinical Classification.
Acta Pathol Microbiol Scand, 64 (1965), pp. 31-49
[28.]
S.I. Smith, K.S. Oyedeji, A.O. Arigbabu, et al.
Comparison of three PCR methods for detection of Helicobacter pylori DNA and detection of cagA gene in gastric biopsy specimens.
World J Gastroenterol, 10 (2004), pp. 1958-1960
[29.]
V.J. Johnson, B. Yucesoy, M.I. Luster.
Genotyping of single nucleotide polymorphisms in cytokine genes using realtime PCR allelic discrimination technology.
Cytokine, 27 (2004), pp. 135-141
[30.]
N. Buchs, F.S. di Giovine, T. Silvestri, et al.
IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels.
Genes Immun, 2 (2001), pp. 222-228
[31.]
F. Perri, A. Piepoli, C. Bonvicini, et al.
Cytokine gene polymorphisms in gastric cancer patients from two Italian areas at high and low cancer prevalence.
Cytokine, 30 (2005), pp. 293-302
[32.]
M. Camorlinga-Ponce, J. Torres, G. Pérez-Pérez, et al.
Validation of a serologic test for the diagnosis of Helicobacter pylori infection and the immune response to urease and CagA in children.
Am J Gastroenterol, 93 (1998), pp. 1264-1270
[33.]
M. Camorlinga-Ponce, L. Flores-Luna, E. Lazcano-Ponce, et al.
Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
Cancer Epidemiol Biomarkers Prev, 17 (2008), pp. 2498-2504
[34.]
T. Martínez, G. Hernández, C. Rojas.
La dieta y su asociación con lesiones preneoplásicas y cáncer gástrico en una zona de alto riesgo para cáncer gástrico en Colombia I, 2000–2006.
Revista Colombiana de Cancerología, 12 (2008), pp. 74-88
[35.]
R. Rad, C. Prinz, B. Neu, et al.
Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa.
J Infect Dis, 188 (2003), pp. 272-281
[36.]
W.P. Arend, M. Malyak, C.J. Guthridge, et al.
Interleukin-1 receptor antagonist: role in biology.
Annu Rev Immunol, 16 (1998), pp. 27-55
[37.]
R. Rad, A. Dossumbekova, B. Neu, et al.
Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonization during Helicobacter pylori infection.
Gut, 53 (2004), pp. 1082-1089
[38.]
W. Alpizar-Alpizar, G.I. Pérez-Pérez, C. Une, et al.
Association of interleukin-1B and interleukin-1RN polymorphisms with gastric cancer in a high-risk population of Costa Rica.
Clin Exp Med, 5 (2005), pp. 169-176
[39.]
S.A. Con, H. Takeuchi, G.R. Con-Chin, et al.
Role of bacterial and genetic factors in gastric cancer in Costa Rica.
World J Gastroenterol, 15 (2009), pp. 211-218
[40.]
H.P. Melo Barbosa, L.C. Martins, S.E. Dos Santos, et al.
Interleukin-1 and TNF-alpha polymorphisms and Helicobacter pylori in a Brazilian Amazon population.
World J Gastroenterol, 15 (2009), pp. 1465-1471
[41.]
M. Canas, Y. Moran, M.B. Rivero, et al.
Interleukin-1 genetic polymorphism: association with gastric cancer in the highrisk Central-Western population of Venezuela.
Rev Med Chil, 137 (2009), pp. 63-70
[42.]
D.R. Morgan, R.L. Dominguez, T.O. Keku, et al.
Gastric cancer and the high combination prevalence of host cytokine genotypes and Helicobacter pylori in Honduras.
Clin Gastroenterol Hepatol, 4 (2006), pp. 1103-1111
[43.]
E. Garza-González, F.J. Bosques-Padilla, E. El-Omar, et al.
Role of the polymorphic IL-1B, IL-1RN and TNF-A genes in distal gastric cancer in Mexico.
Int J Cancer, 114 (2005), pp. 237-241
[44.]
M.A. García-González, A. Lanas, S. Santolaria, et al.
The polymorphic IL-1B and IL-1RN genes in the aetiopathogenesis of peptic ulcer.
Clin Exp Immunol, 125 (2001), pp. 368-375
[45.]
Q. Mei, J.M. Xu, H.L. Cao, et al.
Associations of the IL-1 and TNF gene polymorphisms in the susceptibility to duodenal ulcer disease in Chinese Han population.
Int J Immunogenet, 37 (2009), pp. 9-12
[46.]
L.A. Sicinschi, L. López-Carrillo, M.C. Camargo, et al.
Gastric cancer risk in a Mexican population: role of Helicobacter pylori CagA positive infection and polymorphisms in interleukin- 1 and -10 genes.
Int J Cancer, 118 (2006), pp. 649-657
[47.]
L.L. Gatti, R.R. Burbano, P.P. de Assumpcao, et al.
Interleukin- 1beta polymorphisms. Helicobacter pylori infection in individuals from Northern Brazil with gastric adenocarcinoma.
Clin Exp Med, 4 (2004), pp. 93-98
[48.]
C. Rodas, N. Gelvez, G. Keyeux.
Mitochondrial DNA studies show asymmetrical Amerindian admixture in Afro- Colombian and mestizo populations.
Hum Biol, 75 (2003), pp. 13-30
[49.]
C. Li, H.H. Xia, W. Xie, et al.
Association between interleukin- 1 gene polymorphisms and Helicobacter pylori infection in gastric carcinogenesis in a Chinese population.
J Gastroenterol Hepatol, 22 (2007), pp. 234-239
[50.]
R. Sierra, C. Une, V. Ramírez, et al.
Relation of atrophic gastritis with Helicobacter pylori-CagA(+) and interleukin-1 gene polymorphisms.
World J Gastroenterol, 14 (2008), pp. 6481-6487
[51.]
P.I. Hsu, C.N. Li, H.H. Tseng, et al.
The interleukin-1 RN polymorphism and Helicobacter pylori infection in the development of duodenal ulcer.
Helicobacter, 9 (2004), pp. 605-613
[52.]
M. Chakravorty, A. Ghosh, A. Choudhury, et al.
Interaction between IL1B gene promoter polymorphisms in determining susceptibility to Helicobacter pylori associated duodenal ulcer.
Hum Mutat, 27 (2006), pp. 411-419
[53.]
R. Goll, F. Gruber, T. Olsen, et al.
Helicobacter pylori stimulates a mixed adaptive immune response with a strong T-regulatory component in human gastric mucosa.
Helicobacter, 12 (2007), pp. 185-192
[54.]
E. Stromberg, A. Lundgren, A. Edebo, et al.
Increased frequency of activated T-cells in the Helicobacter pylori-infected antrum and duodenum.
FEMS Immunol Med Microbiol, 36 (2003), pp. 159-168
[55.]
I.L. Beales, J. Calam.
Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways.
Gut, 42 (1998), pp. 227-234
[56.]
J.C. Machado, C. Figueiredo, P. Canedo, et al.
A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma.
Gastroenterology, 125 (2003), pp. 364-371
[57.]
M. Sugimoto, T. Furuta, N. Shirai, et al.
Different effects of polymorphisms of tumor necrosis factor-alpha and interleukin- 1 beta on development of peptic ulcer and gastric cancer.
J Gastroenterol Hepatol, 22 (2007), pp. 51-59
[58.]
O. Partida-Rodríguez, J. Torres, L. Flores-Luna, et al.
Polymorphisms in TNF and HSP-70 show a significant association with gastric cancer and duodenal ulcer.
Int J Cancer, 126 (2010), pp. 1861-1868
[59.]
C. Li, B. Xia, Y. Yang, et al.
TNF gene polymorphisms and Helicobacter Pylori infection in gastric carcinogenesis in Chinese population.
Am J Gastroenterol, 100 (2005), pp. 290-294
[60.]
E. Kunstmann, C. Epplen, E. Elitok, et al.
Helicobacter pylori infection and polymorphisms in the tumor necrosis factor region.
Electrophoresis, 20 (1999), pp. 1756-1761
[61.]
G. Klausz, A. Tiszai, L. Tiszlavicz, et al.
Local and peripheral cytokine response and CagA status of Helicobacter pylori- positive patients with duodenal ulcer.
Eur Cytokine Netw, 14 (2003), pp. 143-148
[62.]
K.W. Moore, R. de Waal Malefyt, R.L. Coffman, et al.
Interleukin-10 and the interleukin-10 receptor.
Annu Rev Immunol, 19 (2001), pp. 683-765
[63.]
B.S. Lundin, K. Enarsson, B. Kindlund, et al.
The local and systemic T-cell response to Helicobacter pylori in gastric cancer patients is characterised by production of interleukin- 10.
Clin Immunol, 125 (2007), pp. 205-213
[64.]
E.M. El-Omar, C.S. Rabkin, M.D. Gammon, et al.
Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms.
Gastroenterology, 124 (2003), pp. 1193-1201
[65.]
H.H. Won, J.W. Kim, M.J. Kim, et al.
Interleukin 10 polymorphisms differentially influence the risk of gastric cancer in East Asians and Caucasians.
Cytokine, 51 (2010), pp. 73-77
[66.]
M. Sugimoto, T. Furuta, N. Shirai, et al.
Effects of interleukin- 10 gene polymorphism on the development of gastric cancer and peptic ulcer in Japanese subjects.
J Gastroenterol Hepatol, 22 (2007), pp. 1443-1449
[67.]
J.Q. Huang, G.F. Zheng, K. Sumanac, et al.
Meta-analysis of the relationship between cagA seropositivity and gastric cancer.
Gastroenterology, 125 (2003), pp. 1636-1644
[68.]
D. Palli, G. Masala, G. Del Giudice, et al.
CagA+ Helicobacter pylori infection and gastric cancer risk in the EPICEURGAST study.
Int J Cancer, 120 (2007), pp. 859-867
[69.]
A. Pietroiusti, I. Luzzi, M.J. Gomez, et al.
Helicobacter pylori duodenal colonization is a strong risk factor for the development of duodenal ulcer.
Aliment Pharmacol Ther, 21 (2005), pp. 909-915
[70.]
F.I. Tovey, M. Hobsley, J. Holton.
Helicobacter pylori virulence factors in duodenal ulceration: A primary cause or a secondary infection causing chronicity.
World J Gastroenterol, 12 (2006), pp. 6-9
[71.]
P.B. Boulos, A. Botha, M. Hobsley, et al.
Possible absence of Helicobacter pylori in the early stages of duodenal ulceration.
Qjm, 95 (2002), pp. 749-752
[72.]
Y. Yamaoka, J. Souchek, S. Odenbreit, et al.
Discrimination between cases of duodenal ulcer and gastritis on the basis of putative virulence factors of Helicobacter pylori.
J Clin Microbiol, 40 (2002), pp. 2244-2246
[73.]
L.E. Hansson, O. Nyren, A.W. Hsing, et al.
The risk of stomach cancer in patients with gastric or duodenal ulcer disease.
N Engl J Med, 335 (1996), pp. 242-249
[74.]
T. Tsukui, R. Kashiwagi, M. Sakane, et al.
Aging increases, and duodenal ulcer reduces the risk for intestinal metaplasia of the gastric corpus in Japanese patients with dyspepsia.
J Gastroenterol Hepatol, 16 (2001), pp. 15-21
[75.]
K. Kimura, P. Sipponen, P. Unge, et al.
Comparison of gastric histology among Swedish and Japanese patients with peptic ulcer and Helicobacter pylori infection.
Scand J Gastroenterol, 38 (2003), pp. 491-497
[76.]
H.M.T. El-Zimaity, O. Gutierrez, J.G. Kim, et al.
Geographic differences in the distribution of intestinal metaplasia in duodenal ulcer patients.
Am J Gastroenterol, 96 (2001), pp. 666-672
[77.]
A. Ramírez Ramos, S. Recavarren Arce, J. Arias Stella, et al.
[Helicobacter Pylori, Chronic Gastritis, Gastric Andduodenal Ulcer: Study of 1638 Patients].
Rev Gastroenterol Peru, 19 (1999), pp. 196-201
[78.]
D. Kumar, A. Dhar, S. Dattagupta, et al.
Pre and post eradication gastric inflammation in Helicobacter pylori-associated duodenal ulcer.
Indian J Gastroenterol, 21 (2002), pp. 7-10
[79.]
S.J. Cho, I.J. Choi, C.G. Kim, et al.
Risk factors associated with gastric cancer in patients with a duodenal ulcer.
Helicobacter, 15 (2010), pp. 516-523
Copyright © 2011. Instituto Nacional de Cancerología
